Within each tissue section, eight regions of interest (ROI) were selected and segmented into immune (CD45+), tumor (PanCK+), and stromal (CD45−/PanCK−) compartments, enabling compartment-specific transcriptomic analysis. Here, PTPRC is linked to neoplasm.